Navigation Links
Early safety results promising for Phase I/II trial of gene therapy treatment of hemophilia B
Date:12/6/2010

DNA. Participants received no immune suppressing drugs prior to infusion of the experimental vector.

Results so far suggest the experimental vector does not trigger the T-cell mediated immune response seen in a previous hemophilia B gene therapy trial.

The third and highest dose of the novel gene-vector combination is scheduled to be infused into the fifth and sixth study participants by mid-January. Investigators will then decide whether to expand the trial to include four more adults with severe hemophilia B. Study participants were all recruited at UCL/Royal Free Hospital through the efforts of co-author Edward G.D. Tuddenham, M.D.

Davidoff and Nathwani noted that hemophilia B has been the main focus of gene therapy efforts for disorders affecting the liver because the threshold required for therapeutic effect is modest. In patients with severe hemophilia B whose baseline level of Factor IX is less than 1 percent, generating expression of just 5 percent has the potential to dramatically affect their quality of life, reducing disabling and painful episodes of bleeding and eliminating the need for costly infusions of the protein.

Factor IX is needed for normal clot formation. A mutation in the gene that carries instructions for assembling the protein leaves about 1 in 30,000 individuals at risk for disabling episodes of internal and external bleeding. The gene is carried on the X chromosome, and the disorder is almost exclusively a male disease.

The trial vector was made at the Children's Good Manufacturing Practices (GMP), LLC, facility, on the St. Jude campus. The GMP operates under government-approved manufacturing guidelines and produces the highly specialized medicines and vaccines that pharmaceutical companies are reluctant to pursue.


'/>"/>

Contact: Summer Freeman
summer.freeman@stjude.org
901-595-3061
St. Jude Children's Research Hospital
Source:Eurekalert

Page: 1 2

Related biology news :

1. SomaLogic researchers describe revolutionary new approach to protein analysis and application to early diagnosis of lung cancer
2. U of M researcher helps unlock 30 new genes responsible for early onset puberty
3. UGA researchers identify key enzyme that regulates the early growth of breast cancer cells
4. PAREXEL Completes 200 Patient Studies In Its Early Phase Units Over Three Years
5. Arsenic early in treatment improves survival for leukemia patients
6. Brookhaven chemist Jacob Hooker receives Presidential Early Career Award
7. Studying the metabolome of smokers, Lombardi researchers find early signs of damage
8. UV light nearly doubles vacuums effectiveness in reducing carpet microbes
9. Found: First complete remains of early sauropod dinosaur
10. Early role of mitochondria in AD may help explain limitations to current beta amyloid hypothesis
11. JCI online early table of contents: Oct. 11, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/25/2015)... 25, 2015  ABC Financial Services (ABC), the ... Health and Fitness Industry, today announced enhancements to ... The latest upgrade includes advances to the agreement ... check-in via Identity One fingerprint biometrics. The features ... interactive displays at the International Health, Racquet & ...
(Date:2/24/2015)... Feb. 24, 2015 This report analyzes the worldwide ... separate comprehensive analytics for the US, Canada ... , Asia-Pacific , Middle East ... estimates and forecasts are provided for the period 2013 through ... markets. Market data and analytics are derived from primary and ...
(Date:2/24/2015)... report analyzes the worldwide markets for Face and Voice Biometrics in ... The report provides separate comprehensive analytics for the US, ... , Asia-Pacific , Middle East ... Latin America . Annual estimates and forecasts are provided for ... provided for these markets. Market data and analytics are derived from ...
Breaking Biology News(10 mins):ABC Financial Unveils New Software Enhancements 2ABC Financial Unveils New Software Enhancements 3World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11World Face and Voice Biometrics Industry 2World Face and Voice Biometrics Industry 3World Face and Voice Biometrics Industry 4World Face and Voice Biometrics Industry 5World Face and Voice Biometrics Industry 6World Face and Voice Biometrics Industry 7World Face and Voice Biometrics Industry 8World Face and Voice Biometrics Industry 9World Face and Voice Biometrics Industry 10World Face and Voice Biometrics Industry 11World Face and Voice Biometrics Industry 12World Face and Voice Biometrics Industry 13World Face and Voice Biometrics Industry 14World Face and Voice Biometrics Industry 15World Face and Voice Biometrics Industry 16
... University of Toronto (U of T) have found that ... species opts for sexual over asexual reproduction. The ... Aneil Agrawal of the Department of Ecology & Evolutionary ... habitats characterized by uneven concentrations of its own ...
... Inc. (Nasdaq: AWRE ), a leading technology innovator ... a conference call to discuss the company,s operating results for ... 5:00 p.m. Eastern Time. President and CEO Edmund Reiter and ... This call is being webcast by Thomson and can ...
... A team of biomedical engineers from Columbia University, University ... million dollar, five-year Multi University Research Initiative (MURI) grant from ... blast waves on the neural circuitry of the brain. ... improvised explosive devices (IEDs), blast-induced traumatic brain injury (TBI) has ...
Cached Biology News:Aware, Inc. Announces Q3'10 Earnings Conference Call 2Columbia engineer part of team to receive $6.2 million DOD grant for blast research 2
(Date:2/28/2015)... February 28, 2015 Increasing its efforts to ... launches its first three episodes of The GMO TRUTH podcast ... this month, as it continues its mission to discover the ... project's first phase, to “uncover the truth about the GMOs ... , The GMO Truth Podcast is an expansion of the ...
(Date:2/27/2015)... Immunovaccine Inc. (“Immunovaccine” or the “Company”) ... press release disseminated this morning by PR Web, and ... press release states that Immunovaccine has entered into a ... release did not originate from Immunovaccine and there is ... release. Please note that all official statements by ...
(Date:2/27/2015)... Md. and SUMMERLAND, British Columbia ... (NYSE: XON ), a leader in ... agreement to acquire  Okanagan Specialty Fruits (OSF), the ... apple , the world,s first non-browning apple. Through the ... yielding fruit that is more appetizing and convenient for ...
(Date:2/27/2015)... 2015  Pharmacyclics, Inc. (NASDAQ: PCYC ... its newly developed Bruton,s tyrosine kinase (BTK) inhibitor ... The results of these preclinical evaluations have been ... The feedback received from the Agency is supportive ... Additional preclinical work is required to begin a ...
Breaking Biology Technology:The Walk a Mile Project Launches “GMO Truth” Podcast 2Immunovaccine Disclaims Hoax Press Release 2Intrexon to Acquire Okanagan Specialty Fruits 2Intrexon to Acquire Okanagan Specialty Fruits 3Intrexon to Acquire Okanagan Specialty Fruits 4Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3
... Aug. 14 /Xinhua-PRNewswire-FirstCall/ -- China Sky One,Medical, ... Company,) (Amex: CSY ), a,leading fully ... in the People,s Republic of China ("PRC"), ... spray for the treatment,and prevention of rheumatic ...
... Technology ... ... (Nasdaq: PRXL ), a leading global biopharmaceutical services,organization, today ... leading clinical technology organization. By combining,ClinPhone with Perceptive Informatics, PAREXEL,s ...
... to Host Conference Call at 4:30 p.m. ET Today -, ... ) today reported financial results for its fourth quarter,and fiscal ... fourth quarter of,fiscal 2008 was $4.6 million, or $0.18 per ... per share, for the fourth quarter of fiscal 2007., ...
Cached Biology Technology:China Sky One Medical, Inc. Develops Nasal Spray for Rheumatic Disease 2China Sky One Medical, Inc. Develops Nasal Spray for Rheumatic Disease 3PAREXEL Closes the Acquisition of ClinPhone 2PAREXEL Closes the Acquisition of ClinPhone 3PAREXEL Closes the Acquisition of ClinPhone 4PAREXEL Closes the Acquisition of ClinPhone 5Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results 2Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results 3Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results 4Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results 5Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results 6
...
Mouse monoclonal [2G1] to Vancomycin ( Abpromise for all tested applications)....
Rab1A...
... polyclonal to LYZL6 ( Abpromise ... Antigen: Synthetic peptide: DWLCL ... , corresponding to amino acids 46-100 ... Entrez Gene ID: 57151 ...
Biology Products: